Compared to treatment with IgG control antibody, a monoclonal antibody against CD47, B6H12, enhanced the in vitro phagocytotic activity of human macrophages against cancer cells and prolonged the survival of mice with intraperitoneal metastatic cancer (56). Here, CD47 is linked to cancer.